T
Theriva Biologics, Inc. (TOVX)
ASE – Real Time Price. Currency in USD
0.32
-0.02 (-5.60%)
At close: May 12, 2026, 4:00 PM EDT
0.33
+0.01 (2.52%)
After-hours: May 12, 2026, 7:59 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
ASE – Real Time Price. Currency in USD
0.32
-0.02 (-5.60%)
At close: May 12, 2026, 4:00 PM EDT
0.33
+0.01 (2.52%)
After-hours: May 12, 2026, 7:59 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
Company's cash reserves $14.4M significantly exceed its total debt $3.7M, ensuring strong financial flexibility
Total current assets $16.8M exceed Total current liabilities $10.3M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$2.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 1.63 | 6.05 | 8.0 | |
| Quick ratio | 1.63 | 5.63 | 8.0 | |
| Debt to Equity | 0.24 | 0.30 | 8.0 | |
| Debt to Assets | 0.10 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 6.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | 300K |
| Gross Profit | -268K | -135K | -137K | -108K | 194K |
| Operating Income | -19M | -22M | -19M | -15M | -13M |
| Net Income | -20M | -18M | -26M | -24M | -21M |
| EBITDA | -19M | -22M | -19M | -15M | -13M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 97.15 | 5.5 |
| Next quarter | N/A | 86.67 | 5.5 |
| Current year | N/A | 89.18 | 5.5 |
| Next year | N/A | -6.67 | 1.0 |
| Weighted average score | 4.4 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -2.39 | -102.69 | 14.78 | 5.0 |
| Y/Y | 999 | 52.73 | 96.77 | 48.36 | 10 |
| 3y average | 999 | -7.98 | 45.09 | 4.38 | 6.3 |
| 5y average | 999 | -21.26 | 47.51 | -8.31 | 5.5 |
| Weighted average score | 6.7 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |